시장보고서
상품코드
1467258

세계의 농업 바이오테크놀러지 시장

Agricultural Biotechnology

발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 263 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

농업 바이오테크놀러지 세계 시장은 2030년까지 889억 달러에 이를 전망

2023년에 477억 달러에 이른 것으로 추정되는 농업 바이오테크놀러지 세계 시장은 2023-2030년간 CAGR 8.1%로 성장하여 2030년에는 889억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 분자진단은 CAGR 9.3%를 나타내고, 분석 기간 종료시에는 356억 달러에 이를 것으로 예측됩니다. 조직배양 분야의 성장은 향후 8년간 연평균 복합 성장률(CAGR)이 8.7%를 나타낼 전망입니다.

미국 시장은 추정 142억 달러, 중국은 CAGR 7.5%로 성장 예측

미국의 농업 바이오테크놀러지 시장은 2023년에는 142억 달러에 이를 것으로 추정됩니다. 세계 2위 경제대국인 중국은 2023년부터 2030년까지 분석 기간에 CAGR 7.5%로 성장을 지속하여, 2030년까지 152억 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역 시장으로서는 일본과 캐나다가 있으며, 각각 2023-2030년간 7.3%와 6.6%의 성장이 예측됩니다. 유럽에서는 독일이 CAGR 약 6.1%로 성장할 것으로 예측됩니다.

2024년에 새롭게 선보이는 흥미로운 보고서 기능 소개

기업 관여 통계에 풀 액세스

디지털 아카이브와 'MarketGlass' 조사 플랫폼에의 무료 액세스. 당사의 독자적인 MarketGlass 플랫폼은 전 세계 전문가들의 창의성과 시장 지식을 통합적이고 협력적으로 발휘할 수 있도록 지원합니다. 당사의 최첨단 툴은 시장 진출기업의 프라이버시와 신원을 보호하면서, 세계 클래스의 시장 전망을 제공합니다. 보고서의 수치, 통계 및 시장 설명은 이 분야의 전문가와 영향력 있는 사람들이 공유한 엄선된 통찰력을 기반으로 한다.

실시간 데이터 시뮬레이터 및 툴이나 특수 보고서 작성 기능을 갖춘 인터랙티브인 설문조사에 참가하실 수 있습니다.

기업간 스마트한 의견교환을 위한 피어 협업 및 인터랙티브 플랫폼에의 풀 클라이언트 액세스

1년간 무료 보고서 업데이트

주요 기업과 세계 시장 점유율을 포함한 경쟁 커버리지

여러 지역에서 기업의 시장 입지 분석(호조/활발/틈새/마이너)

전문가/기업 인터뷰, 팟캐스트, 프레스 발표, 이벤트 기조 강연 YouTube 비디오에의 액세스

2024년 세계 경제에 기대하는 것

금융긴축과 그에 따른 금리 상승에 의해서 일으켜지는 지정학적, 경제적 불안정성이 2024년의 격동적인 상황을 만들어낼 것으로 예상됩니다. 중동에서의 적대 행위나, 더욱 더 빈발하는 기후 재해 등, 몇개의 요인이 회복으로 가는 길에 계속 압력을 가할 것으로 예상됩니다. 한편, 디스인플레 징후가 강해지고, 완미한 인플레이션에 대한 불안이 완화되어 공급망이 정상화되고, 에너지 비용 변동에도 불구하고 물가가 완만하게 되는 등, 몇 가지 긍정적인 요소도 구체화되고 있습니다. 인도나 미국을 시작으로 하는 G21 국가 선거는 자본 흐름이나 투자 전략에 영향을 미칠 가능성이 있습니다. 인도가 세계적인 투자처로서 주목받는 한편, 미국을 거점으로 하는 하이테크 기업은 재능과 자본 다이나믹한 에코시스템에 힘입어 계속 우위를 유지할 것으로 예상됩니다. 실리콘밸리를 시작으로 하는 하이테크 기회는 국내 경제가 감속하고 있다고는 해도 안정적이고, 규제 환경도 정비되고 있기 때문에 고성장 가능성을 요구하는 투자자에 있어서 계속 매력적입니다. 유럽은 금융긴축 정책과 경기후퇴 리스크와의 싸움이 계속되지만, 영국은 전망이 가장 어렵고, 2024년 경기후퇴 리스크가 가장 높습니다. 중국은 정부지출과 개인소비 개선에 힘입어 성장이 기대되는 와일드 카드가 될 것입니다. 불안정한 환경은 투자자에게도 기업에게도, 기회와 과제 양쪽 모두를 가져올 것으로 생각됩니다. 성장에의 기폭제로서 변동성을 받아들임과 동시에, 투자 판단 민첩성과 전략적 선견성이 살아 남기 위해서 중요한 것으로 변화는 없습니다.

조사 대상 기업 예

  • ADAMA Agricultural Solutions Ltd.
  • BASF SE
  • Bayer CropScience AG
  • Certis USA LLC
  • Dow AgroSciences LLC
  • DuPont Pioneer
  • Marrone Bio Innovations Inc.
  • Monsanto Company
  • Performance Plants Inc.
  • Syngenta AG
  • Valent BioSciences Corporation

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 세계 기타 지역

제4장 경쟁

LSH 24.05.17

Global Agricultural Biotechnology Market to Reach $88.9 Billion by 2030

The global market for Agricultural Biotechnology estimated at US$47.7 Billion in the year 2023, is expected to reach US$88.9 Billion by 2030, growing at a CAGR of 8.1% over the period 2023-2030. Molecular Diagnostics, one of the segments analyzed in the report, is expected to record 9.3% CAGR and reach US$35.6 Billion by the end of the analysis period. Growth in the Tissue Culture segment is estimated at 8.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $14.2 Billion, While China is Forecast to Grow at 7.5% CAGR

The Agricultural Biotechnology market in the U.S. is estimated at US$14.2 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$15.2 Billion by the year 2030 trailing a CAGR of 7.5% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.3% and 6.6% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 17 Featured) -

  • ADAMA Agricultural Solutions Ltd.
  • BASF SE
  • Bayer CropScience AG
  • Certis USA LLC
  • Dow AgroSciences LLC
  • DuPont Pioneer
  • Marrone Bio Innovations Inc.
  • Monsanto Company
  • Performance Plants Inc.
  • Syngenta AG
  • Valent BioSciences Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Prelude
    • Recent Market Activity
    • Widening Gap between Food Demand and Production Raises Significance of Agricultural Biotechnology
    • Opportunity Indicators in a Nutshell
    • Transgenic Seeds & Crops Spearhead Growth in the Agricultural Biotech Market
    • Highlights
    • Significant Benefits of GM Crops Augur Well for Market Growth
    • Biotech Cropland Worldwide - An Overview
    • Developed Regions Lead GM Crop Cultivation, Developing Regions Promise Future Growth
    • Barriers to Expansion of Biotechnology in Agriculture Industry
    • Bt. Cotton: Adoption All Set to Increase Further in the Coming Years
    • Robust R&D Pipeline to Play a Pivotal Role in Adoption of Bt. Cotton
    • Challenges Hindering Wider Adoption of GM Crops
    • Biopesticides: Natural Attributes Spur Global Demand
    • Developed Countries: Leading Consumers of Biopesticides
    • Biopesticides - A Crucial Component for Implementing Integrated Pest Management
    • Explosive Growth in Organic Farming Augurs Well for Biopesticides Market
    • Lack of Familiarity & Negative Perceptions Hinder Uptake of Biopesticides among Farmers
    • Biopesticide Regulations in the US and Europe
    • Agricultural Biotechnology - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
    • ADAMA Agricultural Solutions Ltd. (Israel)
    • BASF SE (Germany)
    • Bayer CropScience AG (Germany)
    • Certis USA LLC (USA)
    • Dow AgroSciences, LLC (USA)
    • Mycogen Seeds (USA)
    • DuPont Pioneer (USA)
    • Marrone Bio Innovations, Inc. (USA)
    • Monsanto Company (USA)
    • Performance Plants, Inc. (Canada)
    • Syngenta AG (Switzerland)
    • Valent BioSciences Corporation (USA)
  • 3. MARKET TRENDS & DRIVERS
    • Food Security - An Opportunity Generator
    • Rising Demand for Biofuels: Positive Implications for GM Crops Market
    • Introduction of Bt Cotton and Bt Brinjal Enhance Agricultural Production
    • IRRI Working to Develop Stress-Tolerant Rice Variants
    • Advent of Insect Resistant Crops Fuel Growth for Agriculture Industry
    • Global Reservations Persist in Acknowledging Benefits of GM Crops
    • Integration of Biotechnology and IT Revolutionizes Agriculture Sector
    • Development of New Herbicide-Tolerant Traits Gathers Steam
    • Advanced Farming Techniques for Increasing Agricultural Yields
    • Misuse of Indigenous Resources of Developing Countries: A Cause of Concern
    • Educating Consumers - Need of the Hour
    • Synthetic Biology - A Brief Review
    • Synthetic Biology: Prediction Becoming Reality
    • Biostimulants: Growing Interest in Organic Food to Propel Growth
    • Need for Sustainable Agriculture - Key Growth Driver
    • Lack of Thorough Research Impedes Growth in Biostimulants Market
    • Need for Paradigm Shift in Grower Mindset Regarding Biostimulants
    • The Road Ahead
    • Sales of Non-GMO products to Register Impressive Growth
    • Public-Private Sector Partnerships Gain Importance
    • Protection of Intellectual Property Demands High Attention
    • Challenges Aplenty for Agricultural Biotechnology in Developing Nations
    • Dearth of Competent Leadership
    • Insufficient Financial Support for R&D
    • Lack of Scientific and Technological Infrastructure
    • Insufficient Expertise and Human Resources
    • Safety Issues
    • Ethical Issues
    • Lack of Regulatory Framework
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Tissue Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Tissue Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Tissue Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Genetic Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Transgenic Crops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Transgenic Crops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Transgenic Crops by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Synthetic Biology-enabled Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Synthetic Biology-enabled Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Synthetic Biology-enabled Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Agricultural Biotechnology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Agricultural Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Agricultural Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Agricultural Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Agricultural Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Agricultural Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Agricultural Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Agricultural Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Agricultural Biotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Agricultural Biotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Agricultural Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Agricultural Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Agricultural Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Agricultural Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Agricultural Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제